Literature DB >> 12734516

Potentially fatal interstitial lung disease can occur in clinically amyopathic dermatomyositis.

Richard D Sontheimer, Sachiko Miyagawa.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12734516     DOI： 10.1067/mjd.2003.199

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  11 in total

1.  Early assessment of rapidly progressive interstitial pneumonia associated with amyopathic dermatomyositis.

Authors:  Eishi Miyazaki; Masaru Ando; Tomoko Muramatsu; Tetsujiro Fukami; Osamu Matsuno; Shin-Ichi Nureki; Takuya Ueno; Tomiyasu Tsuda; Toshihide Kumamoto
Journal:  Clin Rheumatol       Date:  2005-12-20       Impact factor: 2.980

2.  Interstitial lung disease in clinically amyopathic dermatomyositis (CADM) patients: a retrospective study of 41 Chinese Han patients.

Authors:  Yuechi Sun; Yuan Liu; Bing Yan; Guixiu Shi
Journal:  Rheumatol Int       Date:  2012-11-10       Impact factor: 2.631

3.  Adult clinically amyopathic dermatomyositis with rapid progressive interstitial lung disease: a retrospective cohort study.

Authors:  Shuang Ye; Xiao-xiang Chen; Xiao-ye Lu; Mei-fang Wu; Yun Deng; Wen-qun Huang; Qiang Guo; Cheng-de Yang; Yue-ying Gu; Chun-de Bao; Shun-le Chen
Journal:  Clin Rheumatol       Date:  2007-02-17       Impact factor: 2.980

4.  Intravenous immunoglobulin therapy for refractory interstitial lung disease associated with polymyositis/dermatomyositis.

Authors:  Yuzo Suzuki; Hiroshi Hayakawa; Seiichi Miwa; Masahiro Shirai; Masato Fujii; Hitoshi Gemma; Takafumi Suda; Kingo Chida
Journal:  Lung       Date:  2009-04-22       Impact factor: 2.584

5.  Successful treatment with tacrolimus of progressive interstitial pneumonia associated with amyopathic dermatomyositis refractory to cyclosporine.

Authors:  Masaru Ando; Eishi Miyazaki; Mari Yamasue; Yukiko Sadamura; Toshihiro Ishii; Ryuichi Takenaka; Takeo Ito; Shin-ichi Nureki; Toshihide Kumamoto
Journal:  Clin Rheumatol       Date:  2010-02-04       Impact factor: 3.650

6.  Prognostic factors for myositis-associated interstitial lung disease.

Authors:  Tomoyuki Fujisawa; Hironao Hozumi; Masato Kono; Noriyuki Enomoto; Dai Hashimoto; Yutaro Nakamura; Naoki Inui; Koshi Yokomura; Naoki Koshimizu; Mikio Toyoshima; Toshihiro Shirai; Kazumasa Yasuda; Hiroshi Hayakawa; Takafumi Suda
Journal:  PLoS One       Date:  2014-06-06       Impact factor: 3.240

7.  Lung histopathological pattern in a survivor with rapidly progressive interstitial lung disease and anti-melanoma differentiation-associated gene 5 antibody-positive clinically amyopathic dermatomyositis.

Authors:  Atsushi Suzuki; Yasuhiro Kondoh; Hiroyuki Taniguchi; Kazuhiko Tabata; Tomoki Kimura; Kensuke Kataoka; Kenzo Ono; Mikiko Hashisako; Junya Fukuoka
Journal:  Respir Med Case Rep       Date:  2016-05-28

8.  Interstitial lung disease in clinically amyopathic dermatomyositis with and without anti-MDA-5 antibody: to lump or split?

Authors:  Satoshi Ikeda; Machiko Arita; Mitsunori Morita; Satoshi Ikeo; Akihiro Ito; Fumiaki Tokioka; Maki Noyama; Kenta Misaki; Kenji Notohara; Tadashi Ishida
Journal:  BMC Pulm Med       Date:  2015-12-09       Impact factor: 3.317

9.  Use of High-Flow Nasal Cannula Oxygen Therapy in a Pregnant Woman with Dermatomyositis-Related Interstitial Pneumonia.

Authors:  Tomohiro Shoji; Takeshi Umegaki; Kota Nishimoto; Natsuki Anada; Akiko Ando; Takeo Uba; Munenori Kusunoki; Kanako Oku; Takahiko Kamibayashi
Journal:  Case Rep Crit Care       Date:  2017-12-31

10.  A clinical analysis of risk factors for interstitial lung disease in patients with idiopathic inflammatory myopathy.

Authors:  Xiaomin Cen; Chuan Zuo; Min Yang; Geng Yin; Qibing Xie
Journal:  Clin Dev Immunol       Date:  2013-09-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.